メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の間質血管画分市場

Global Market Study on Stromal Vascular Fraction: Applications in Soft Tissue Prevail, Cosmetic Applications Create Lucrative Opportunities

発行 Persistence Market Research 商品コード 647373
出版日 ページ情報 英文 245 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.44円で換算しております。
Back to Top
世界の間質血管画分市場 Global Market Study on Stromal Vascular Fraction: Applications in Soft Tissue Prevail, Cosmetic Applications Create Lucrative Opportunities
出版日: 2018年04月24日 ページ情報: 英文 245 Pages
概要

当レポートでは、世界の間質血管画分市場について調査し、市場の現状と成長予測、治療タイプ別、エンドユーザー別、用途別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 市場イントロダクション

第3章 市場機会分析

  • マクロ経済因子
  • 機会分析

第4章 市場の背景

  • 技術発展
  • 成長する製造業者リスト
  • バリューチェーン分析
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会分析
  • 法規制シナリオ

第5章 北米市場

第6章 ラテンアメリカ市場

第7章 欧州市場

第8章 アジア太平洋地域市場

第9章 韓国市場

第10章 中東・アフリカ市場

第11章 予測因子:関連性と影響

第12章 予測仮定

第13章 競合分析

  • 競合ダッシュボード
  • ベンチマーキング
  • 競合による荒利幅分析の収益
  • 企業概要
    • Cytori Therapeutics, Inc.
    • GE Healthcare
    • Ingeneron, Inc.
    • Medikan International Inc.
    • Tissue Genesis, Inc.
    • Genesis Biosystems Inc.
    • Human Med AG
    • IntelliCell BioSciences Inc.
    • LifeCell Corporation

第14章 地域別市場分析と予測

第15章 製品別市場分析と予測

第16章 用途別市場分析と予測

第17章 エンドユーザー別市場分析と予測

第18章 世界の分析と予測

目次

Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient's own body. In stromal vascular fraction treatment isolation of tissue contains fat cells, blood cells, and endothelial cells, as well as a large fraction of adipose-derived mesenchymal stem cells which provides regenerative properties and have positive anti-aging properties. A stromal vascular fraction is considered as a personalized stem cell therapy and effective tropical or injectable treatment.

With increasing age, regenerative and repair properties of skin are less effective due to decrease in stem cell count, and therefore, stromal vascular fraction treatment contains stem cell provides a boost in repair and maintenance mechanism of the skin leaving smooth, healthy, radiant skin. Stromal vascular fraction is a naturally occurring stem cell found in bundles of adipose tissues and are the primary source of growth factors along with macrophages and other cells. Due to the presence of growth factors, the stromal vascular fraction is utilized to decrease inflammation present in many diseases. A stromal vascular fraction is adopted in the treatment of rheumatoid arthritis, joint replacement, osteoarthritis, diabetes, Crohn's disease, and others.

Stromal Vascular Fraction Market: Overview

Stromal vascular fraction is a combination of adipose-derived stromal cells (ADSCs), endothelial cells (ECs), endothelial precursor cells (EPCs), smooth muscle cells, macrophages, pericytes, and pre-adipocytes in the aqueous state. Stromal vascular fraction is advantageous over alternative medical treatments as SVF has the ability to regulate patient's own system with the main focus on cell repair and regulation of defective cells. Stromal vascular fraction is a promising field for disease prophylaxis and currently are in clinical trials.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Stromal Vascular Fraction Market: Segmentation

The global stromal vascular fraction market can be segmented on the basis of type of therapy, end-user, and region.

  • By Therapy Type
    • SVF Isolation Products
    • Enzymatic Isolation
    • Non-enzymatic Isolation
    • Automated POC Devices
    • SVF Aspirate Purification Products
    • SVF Transfer Products
  • By End-user
    • Hospitals
    • Specialty Clinics
    • Stem Cell Banks/Laboratories
    • Others
  • By Application
    • Cosmetic
    • Soft-tissue
    • Orthopedic
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific (APAC)
    • South Korea
    • Middle East and Africa (MEA)

In its last part, the report offers insights on the key players competing in the global market for stromal vascular fraction. With detailed profiling of each of the key companies active on the competitive landscape, the report provides information about their current financial scenario, revenue share at a global level, development strategies, and future plans for expansion. Strategic collaborations, mergers, and acquisitions have also been considered as a key strategy among a majority of leading companies in the market.

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Stromal Vascular Fraction Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis

4. Market Background

  • 4.1. Technology Evolution
  • 4.2. List of Growth Hacking Manufacturers
  • 4.3. Value Chain Analysis
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunity Analysis
  • 4.5. Regulatory Scenario

5. North America Stromal Vascular Fraction Market Analysis 2012-2016 and Forecast 2017-2025

  • 5.1. Introduction
  • 5.2. Regional Market Trends
  • 5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 5.3.1. U.S.
    • 5.3.2. Canada
  • 5.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
  • 5.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2012-2016
    • 5.5.1. SVF Isolation Products
      • 5.5.1.1. Enzymatic Isolation
      • 5.5.1.2. Non-enzymatic Isolation
      • 5.5.1.3. Automated POC Devices
    • 5.5.2. SVF Aspirate Purification Products
    • 5.5.3. SVF Transfer Products
  • 5.6. Market Size (US$ Mn) and Forecast By Product Type, 2017-2025
  • 5.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 5.7.1. Cosmetic Applications
    • 5.7.2. Orthopedic Applications
    • 5.7.3. Soft Tissue Applications
    • 5.7.4. Others
  • 5.8. Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 5.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
    • 5.9.1. Hospitals
    • 5.9.2. Specialized Clinics
    • 5.9.3. Stem Cell Laboratories
    • 5.9.4. Others
  • 5.10. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 5.11. Market Attractiveness Analysis
    • 5.11.1. By Country
    • 5.11.2. By Product Type
    • 5.11.3. By Application
    • 5.11.4. By End User
  • 5.12. Drivers and Restraints - Impact Analysis

6. Latin America Stromal Vascular Fraction Market Analysis 2012-2016 and Forecast 2017-2025

  • 6.1. Introduction
  • 6.2. Pricing Analysis
  • 6.3. Regional Market Trends
  • 6.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 6.4.1. Argentina
    • 6.4.2. Brazil
    • 6.4.3. Mexico
    • 6.4.4. Rest of Latin America
  • 6.5. Market Size (US$ Mn) Forecast By Country, 2017-2025
  • 6.6. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2012-2016
    • 6.6.1. SVF Isolation Products
      • 6.6.1.1. Enzymatic Isolation
      • 6.6.1.2. Non-enzymatic Isolation
      • 6.6.1.3. Automated POC Devices
    • 6.6.2. SVF Aspirate Purification Products
    • 6.6.3. SVF Transfer Products
  • 6.7. Market Size (US$ Mn) and Forecast By Product Type, 2017-2025
  • 6.8. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 6.8.1. Cosmetic Applications
    • 6.8.2. Orthopedic Applications
    • 6.8.3. Soft Tissue Applications
    • 6.8.4. Others
  • 6.9. Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 6.10. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
    • 6.10.1. Hospitals
    • 6.10.2. Specialized Clinics
    • 6.10.3. Stem Cell Laboratories
    • 6.10.4. Others
  • 6.11. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 6.12. Market Attractiveness Analysis
    • 6.12.1. By Country
    • 6.12.2. By Product Type
    • 6.12.3. By Application
    • 6.12.4. By End User
  • 6.13. Drivers and Restraints - Impact Analysis

7. Europe Stromal Vascular Fraction Market Analysis 2012-2016 and Forecast 2017-2025

  • 7.1. Introduction
  • 7.2. Regional Market Trends
  • 7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
    • 7.3.1. Germany
    • 7.3.2. U.K.
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe
  • 7.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
  • 7.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2012-2016
    • 7.5.1. SVF Isolation Products
      • 7.5.1.1. Enzymatic Isolation
      • 7.5.1.2. Non-enzymatic Isolation
      • 7.5.1.3. Automated POC Devices
    • 7.5.2. SVF Aspirate Purification Products
    • 7.5.3. SVF Transfer Products
  • 7.6. Market Size (US$ Mn) and Forecast By Product Type, 2017-2025
  • 7.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 7.7.1. Cosmetic Applications
    • 7.7.2. Orthopedic Applications
    • 7.7.3. Soft Tissue Applications
    • 7.7.4. Others
  • 7.8. Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 7.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
    • 7.9.1. Hospitals
    • 7.9.2. Specialized Clinics
    • 7.9.3. Stem Cell Laboratories
    • 7.9.4. Others
  • 7.10. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 7.11. Market Attractiveness Analysis
    • 7.11.1. By Country
    • 7.11.2. By Product Type
    • 7.11.3. By Application
    • 7.11.4. By End User
  • 7.12. Drivers and Restraints - Impact Analysis

8. Asia Pacific Stromal Vascular Fraction Market Analysis 2012-2016 and Forecast 2017-2025

  • 8.1. Introduction
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
    • 8.3.1. Japan
    • 8.3.2. India
    • 8.3.3. Australia and New Zealand
    • 8.3.4. Rest of Asia Pacific
  • 8.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
  • 8.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2012-2016
    • 8.5.1. SVF Isolation Products
      • 8.5.1.1. Enzymatic Isolation
      • 8.5.1.2. Non-enzymatic Isolation
      • 8.5.1.3. Automated POC Devices
    • 8.5.2. SVF Aspirate Purification Products
    • 8.5.3. SVF Transfer Products
  • 8.6. Market Size (US$ Mn) and Forecast By Product Type, 2017-2025
  • 8.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 8.7.1. Cosmetic Applications
    • 8.7.2. Orthopedic Applications
    • 8.7.3. Soft Tissue Applications
    • 8.7.4. Others
  • 8.8. Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 8.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
    • 8.9.1. Hospitals
    • 8.9.2. Specialized Clinics
    • 8.9.3. Stem Cell Laboratories
    • 8.9.4. Others
  • 8.10. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 8.11. Market Attractiveness Analysis
    • 8.11.1. By Country
    • 8.11.2. By Product Type
    • 8.11.3. By Application
    • 8.11.4. By End User
  • 8.12. Drivers and Restraints - Impact Analysis

9. South Korea Stromal Vascular Fraction Market Analysis 2012-2016 and Forecast 2017-2025

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2012-2016
    • 9.2.1. SVF Isolation Products
      • 9.2.1.1. Enzymatic Isolation
      • 9.2.1.2. Non-enzymatic Isolation
      • 9.2.1.3. Automated POC Devices
    • 9.2.2. SVF Aspirate Purification Products
    • 9.2.3. SVF Transfer Products
  • 9.3. Market Size (US$ Mn) and Forecast By Product Type, 2017-2025
  • 9.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 9.4.1. Cosmetic Applications
    • 9.4.2. Orthopedic Applications
    • 9.4.3. Soft Tissue Applications
    • 9.4.4. Others
  • 9.5. Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 9.6. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
    • 9.6.1. Hospitals
    • 9.6.2. Specialized Clinics
    • 9.6.3. Stem Cell Laboratories
    • 9.6.4. Others
  • 9.7. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 9.8. Market Attractiveness Analysis
    • 9.8.1. By Product Type
    • 9.8.2. By Application
    • 9.8.3. By End User
  • 9.9. Drivers and Restraints - Impact Analysis

10. Middle East & Africa Stromal Vascular Fraction Market Analysis 2012-2016 and Forecast 2017-2025

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
    • 10.2.1. GCC Countries
    • 10.2.2. South Africa
    • 10.2.3. Rest of MEA
  • 10.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
  • 10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2012-2016
    • 10.4.1. SVF Isolation Products
      • 10.4.1.1. Enzymatic Isolation
      • 10.4.1.2. Non-enzymatic Isolation
      • 10.4.1.3. Automated POC Devices
    • 10.4.2. SVF Aspirate Purification Products
    • 10.4.3. SVF Transfer Products
  • 10.5. Market Size (US$ Mn) and Forecast By Product Type, 2017-2025
  • 10.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 10.6.1. Cosmetic Applications
    • 10.6.2. Orthopedic Applications
    • 10.6.3. Soft Tissue Applications
    • 10.6.4. Others
  • 10.7. Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 10.8. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
    • 10.8.1. Hospitals
    • 10.8.2. Specialized Clinics
    • 10.8.3. Stem Cell Laboratories
    • 10.8.4. Others
  • 10.9. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 10.10. Market Attractiveness Analysis
    • 10.10.1. By Country
    • 10.10.2. By Product Type
    • 10.10.3. By Application
    • 10.10.4. By End User
  • 10.11. Drivers and Restraints - Impact Analysis

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Analysis

  • 13.1. Competition Dashboard
  • 13.2. Competition Benchmarking
  • 13.3. Profitability and Gross Margin Analysis By Competition
  • 13.4. Company Deep Dive
    • 13.4.1. Cytori Therapeutics, Inc.
      • 13.4.1.1. Overview
      • 13.4.1.2. Product and Application Portfolio
      • 13.4.1.3. Production Footprint
      • 13.4.1.4. Sales Footprint
      • 13.4.1.5. Channel Footprint
      • 13.4.1.6. Strategy
        • 13.4.1.6.1. Marketing Strategy
        • 13.4.1.6.2. Product Strategy
        • 13.4.1.6.3. Channel Strategy
    • 13.4.2. GE Healthcare (Biosafe Group SA)
      • 13.4.2.1. Overview
      • 13.4.2.2. Product and Application Portfolio
      • 13.4.2.3. Production Footprint
      • 13.4.2.4. Sales Footprint
      • 13.4.2.5. Channel Footprint
      • 13.4.2.6. Strategy
        • 13.4.2.6.1. Marketing Strategy
        • 13.4.2.6.2. Product Strategy
        • 13.4.2.6.3. Channel Strategy
    • 13.4.3. Ingeneron, Inc.
      • 13.4.3.1. Overview
      • 13.4.3.2. Product and Application Portfolio
      • 13.4.3.3. Production Footprint
      • 13.4.3.4. Sales Footprint
      • 13.4.3.5. Channel Footprint
      • 13.4.3.6. Strategy
        • 13.4.3.6.1. Marketing Strategy
        • 13.4.3.6.2. Product Strategy
        • 13.4.3.6.3. Channel Strategy
    • 13.4.4. Medikan International Inc.
      • 13.4.4.1. Overview
      • 13.4.4.2. Product and Application Portfolio
      • 13.4.4.3. Production Footprint
      • 13.4.4.4. Sales Footprint
      • 13.4.4.5. Channel Footprint
      • 13.4.4.6. Strategy
        • 13.4.4.6.1. Marketing Strategy
        • 13.4.4.6.2. Product Strategy
        • 13.4.4.6.3. Channel Strategy
    • 13.4.5. Tissue Genesis, Inc.
      • 13.4.5.1. Overview
      • 13.4.5.2. Product and Application Portfolio
      • 13.4.5.3. Production Footprint
      • 13.4.5.4. Sales Footprint
      • 13.4.5.5. Channel Footprint
      • 13.4.5.6. Strategy
        • 13.4.5.6.1. Marketing Strategy
        • 13.4.5.6.2. Product Strategy
        • 13.4.5.6.3. Channel Strategy
    • 13.4.6. Genesis Biosystems Inc.
      • 13.4.6.1. Overview
      • 13.4.6.2. Product and Application Portfolio
      • 13.4.6.3. Production Footprint
      • 13.4.6.4. Sales Footprint
      • 13.4.6.5. Channel Footprint
      • 13.4.6.6. Strategy
        • 13.4.6.6.1. Marketing Strategy
        • 13.4.6.6.2. Product Strategy
        • 13.4.6.6.3. Channel Strategy
    • 13.4.7. Human Med AG
      • 13.4.7.1. Overview
      • 13.4.7.2. Product and Application Portfolio
      • 13.4.7.3. Production Footprint
      • 13.4.7.4. Sales Footprint
      • 13.4.7.5. Channel Footprint
      • 13.4.7.6. Strategy
        • 13.4.7.6.1. Marketing Strategy
        • 13.4.7.6.2. Product Strategy
        • 13.4.7.6.3. Channel Strategy
    • 13.4.8. IntelliCell BioSciences Inc.
      • 13.4.8.1. Overview
      • 13.4.8.2. Product and Application Portfolio
      • 13.4.8.3. Production Footprint
      • 13.4.8.4. Sales Footprint
      • 13.4.8.5. Channel Footprint
      • 13.4.8.6. Strategy
        • 13.4.8.6.1. Marketing Strategy
        • 13.4.8.6.2. Product Strategy
        • 13.4.8.6.3. Channel Strategy
    • 13.4.9. LifeCell Corporation (Allergan PLC.)
      • 13.4.9.1. Overview
      • 13.4.9.2. Product and Application Portfolio
      • 13.4.9.3. Production Footprint
      • 13.4.9.4. Sales Footprint
      • 13.4.9.5. Channel Footprint
      • 13.4.9.6. Strategy
        • 13.4.9.6.1. Marketing Strategy
        • 13.4.9.6.2. Product Strategy
        • 13.4.9.6.3. Channel Strategy

14. Global Stromal Vascular Fraction Market Analysis 2012-2016 and Forecast 2017-2025, By Region

  • 14.1. Introduction/Key Findings
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012-2016
  • 14.3. Market Size (US$ Mn) Forecast By Region, 2017-2025
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. Asia Pacific
    • 14.3.5. Middle East & Africa
    • 14.3.6. China
  • 14.4. Market Attractiveness Analysis By Region

15. Global Stromal Vascular Fraction Analysis 2012-2016 and Forecast 2017-2025, By Product Type

  • 15.1. Introduction/Key Findings
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2012-2016
    • 15.2.1. SVF Isolation Products
      • 15.2.1.1. Enzymatic Isolation
      • 15.2.1.2. Non-enzymatic Isolation
      • 15.2.1.3. Automated POC Devices
    • 15.2.2. SVF Aspirate Purification Products
    • 15.2.3. SVF Transfer Products
  • 15.3. Market Size (US$ Mn) and Forecast By Product Type, 2017-2025
  • 15.4. Market Attractiveness Analysis By Product Type

16. Global Stromal Vascular Fraction Market Analysis 2012-2016 and Forecast 2017-2025, By Application

  • 16.1. Introduction/Key Findings
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 16.2.1. Cosmetic Applications
    • 16.2.2. Orthopedic Applications
    • 16.2.3. Soft Tissue Applications
    • 16.2.4. Others
  • 16.3. Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 16.4. Market Attractiveness Analysis By Application

17. Global Stromal Vascular Fraction Market Analysis 2012-2016 and Forecast 2017-2025, By End User

  • 17.1. Introduction/Key Findings
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
    • 17.2.1. Hospitals
    • 17.2.2. Specialized Clinics
    • 17.2.3. Stem Cell Laboratories
    • 17.2.4. Others
  • 17.3. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 17.4. Market Attractiveness Analysis By End User

18. Global Stromal Vascular Fraction Market Analysis 2012-2016 and Forecast 2017-2025

  • 18.1. Market Value Share Analysis By All Segment
  • 18.2. Y-o-Y Growth Analysis By All Segment
  • 18.3. Absolute $ Opportunity

List of Table:

  • Table 01: Comparison of Cost of Processing Adipose Aspirates Using New Automated Techniques Vs. Traditional Centrifuge Methods
  • Table 02: Pipeline of Cellular Therapies Using SVF
  • Table 03: Pipeline of Cellular Therapies Using SVF
  • Table 04: Pipeline of Cellular Therapies Using SVF
  • Table 05: North America Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 06: North America Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Products
  • Table 07: North America Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
  • Table 08: North America Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
  • Table 09: Latin America Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 10: Latin America Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Products
  • Table 11: Latin America Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
  • Table 12: Latin America Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
  • Table 13: Europe Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 14: Europe Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Products
  • Table 15: Europe Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
  • Table 16: Europe Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
  • Table 17: Asia Pacific Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 18: Asia Pacific Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Products
  • Table 19: Asia Pacific Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
  • Table 20: Asia Pacific Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
  • Table 21: South Korea Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Products
  • Table 22: South Korea Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
  • Table 23: South Korea Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
  • Table 24: MEA Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 25: MEA Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Products
  • Table 26: MEA Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
  • Table 27: MEA Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
  • Table 28: Global Stromal Vascular Fraction Market Size (US$ Mn) 2012-2016 and Forecast 2017-2025 By Region
  • Table 29: Global Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Products
  • Table 30: Global Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
  • Table 31: Global Stromal Vascular Fraction Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User

List of Figure:

  • Figure 01 : Global Stromal Vascular Fraction Market Split By Products, 2017E
  • Figure 02: Global Stromal Vascular Fraction Market Split By Application, 2017E
  • Figure 03: Global Stromal Vascular Fraction Market Split By End User, 2017E
  • Figure 04: Composition of Stromal Vascular Fraction
  • Figure 05: Steps in Stromal Vascular Fraction Preparation for Patient Injection
  • Figure 06: Global Healthcare Expenditure in US$ Tn (2013-2020)
  • Figure 07: Biotechnology Mergers and Acquisition Transactions and Number of deals (2012-2016)
  • Figure 08: Trends in Venture Capital Funding (US$ Bn) in Biotechnology Industry (2012-2017)
  • Figure 09: Distribution of SVF Derived Cell Therapy Clinical Trials By Country
  • Figure 10: Number of Clinical Programs (phase III & phase IV) expected to be completed by 2020, by Application/Indication
  • Figure 11: Opportunities in the SVF Market
  • Figure 12: Opportunity for Suppliers of Consumables
  • Figure 13: Number of Scientific Publication Regarding Development of Stromal Vascular Fraction for Therapeutic Application (2010-2018)
  • Figure 14: Global Distribution of Stromal Vascular Fraction Market Install Base, By Region (2016)
  • Figure 15: Global Distribution of Stromal Vascular Fraction Procedures, By Region (2016)
  • Figure 16: North America Stromal Vascular Fraction Market Value Share, By Country (2017)
  • Figure 17: North America Stromal Vascular Fraction Market Value Share, By Products (2017)
  • Figure 18: North America Stromal Vascular Fraction Market Value Share, By Application (2017)
  • Figure 19: North America Stromal Vascular Fraction Market Value Share, By End User (2017)
  • Figure 20: North America Stromal Vascular Fraction Market Value (US$ Mn) 2017E and 2025F
  • Figure 21: North America Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 22: North America Stromal Vascular Fraction Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 23: U.S. Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 24: U.S. Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 25: Canada Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 26: Canada Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 27: North America Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Isolation Products
  • Figure 28: North America Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Isolation Products
  • Figure 29: North America Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Aspiration Products
  • Figure 30: North America Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Aspiration Products
  • Figure 31: North America Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Transfer Products
  • Figure 32: North America Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Transfer Products
  • Figure 33: North America Stromal Vascular Fraction Market Attractiveness Analysis, By Country
  • Figure 34: North America Stromal Vascular Fraction Market Attractiveness Analysis, By Products
  • Figure 35: North America Stromal Vascular Fraction Market Attractiveness Analysis, By Application
  • Figure 36: North America Stromal Vascular Fraction Market Attractiveness Analysis, By End User
  • Figure 37: North America Stromal Vascular Fraction Market Attractiveness Analysis, By Isolation Products
  • Figure 38: Latin America Stromal Vascular Fraction Market Value Share, By Country (2017)
  • Figure 39: Latin America Stromal Vascular Fraction Market Value Share, By Products (2017)
  • Figure 40: Latin America Stromal Vascular Fraction Market Value Share, By Application (2017)
  • Figure 41: Latin America Stromal Vascular Fraction Market Value Share, By End User (2017)
  • Figure 42: Latin America Stromal Vascular Fraction Market Value (US$ Mn) 2017E and 2025F
  • Figure 43: Latin America Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 44: Latin America Stromal Vascular Fraction Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 45: Brazil Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 46: Brazil Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 47: Mexico Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 48: Mexico Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 49: Rest of Latin America Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 50: Rest of Latin America Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 51: Latin America Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Isolation Products
  • Figure 52: Latin America Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Isolation Products
  • Figure 53: Latin America Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Aspiration Products
  • Figure 54: Latin America Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Aspiration Products
  • Figure 55: Latin America Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Transfer Products
  • Figure 56: Latin America Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Transfer Products
  • Figure 57: Latin America Stromal Vascular Fraction Market Attractiveness Analysis, By Country
  • Figure 58: Latin America Stromal Vascular Fraction Market Attractiveness Analysis, By Products
  • Figure 59: Latin America Stromal Vascular Fraction Market Attractiveness Analysis, By Application
  • Figure 60: Latin America Stromal Vascular Fraction Market Attractiveness Analysis, By End User
  • Figure 61: Latin America Stromal Vascular Fraction Market Attractiveness Analysis, By Isolation Products
  • Figure 62: Europe Stromal Vascular Fraction Market Value Share, By Country (2017)
  • Figure 63: Europe Stromal Vascular Fraction Market Value Share, By Products (2017)
  • Figure 64: Europe Stromal Vascular Fraction Market Value Share, By Application (2017)
  • Figure 65: Europe Stromal Vascular Fraction Market Value Share, By End User (2017)
  • Figure 66: Europe Stromal Vascular Fraction Market Value (US$ Mn) 2017E and 2025F
  • Figure 67: Europe Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 68: Europe Stromal Vascular Fraction Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 69: Germany Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 70: Germany Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 71: Italy Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 72: Italy Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 73: France Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 74: France Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 75: U.K. Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 76: U.K. Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 77: Spain Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 78: Spain Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 79: Russia Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 80: Russia Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 81: Rest of Europe Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 82: Rest of Europe Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 83: Europe Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Isolation Products
  • Figure 84: Europe Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Isolation Products
  • Figure 85: Europe Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Aspiration Products
  • Figure 86: Europe Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Aspiration Products
  • Figure 87: Europe Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Transfer Products
  • Figure 88: Europe Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Transfer Products
  • Figure 89: Europe Stromal Vascular Fraction Market Attractiveness Analysis, By Country
  • Figure 90: Europe Stromal Vascular Fraction Market Attractiveness Analysis, By Products
  • Figure 91: Europe Stromal Vascular Fraction Market Attractiveness Analysis, By Application
  • Figure 92: Europe Stromal Vascular Fraction Market Attractiveness Analysis, By End User
  • Figure 93: Europe Stromal Vascular Fraction Market Attractiveness Analysis, By Isolation Products
  • Figure 94: Asia Pacific Stromal Vascular Fraction Market Value Share, By Country (2017)
  • Figure 95: Asia Pacific Stromal Vascular Fraction Market Value Share, By Products (2017)
  • Figure 96: Asia Pacific Stromal Vascular Fraction Market Value Share, By Application (2017)
  • Figure 97: Asia Pacific Stromal Vascular Fraction Market Value Share, By End User (2017)
  • Figure 98: Asia Pacific Stromal Vascular Fraction Market Value (US$ Mn) 2017E and 2025F
  • Figure 99: Asia Pacific Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 100: Asia Pacific Stromal Vascular Fraction Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 101: Japan Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 102: Japan Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 103: India Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 104: India Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 105: China Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 106: China Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 107: Australia And New Zealand Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 108: Australia And New Zealand Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 109: ASEAN Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 110: ASEAN Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 111: Rest of Asia Pacific Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 112: Rest of Asia Pacific Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 113: Asia Pacific Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Isolation Products
  • Figure 114: Asia Pacific Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Isolation Products
  • Figure 115: Asia Pacific Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Aspiration Products
  • Figure 116: Asia Pacific Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Aspiration Products
  • Figure 117: Asia Pacific Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Transfer Products
  • Figure 118: Asia Pacific Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Transfer Products
  • Figure 119: Asia Pacific Stromal Vascular Fraction Market Attractiveness Analysis, By Country
  • Figure 120: Asia Pacific Stromal Vascular Fraction Market Attractiveness Analysis, By Products
  • Figure 121: Asia Pacific Stromal Vascular Fraction Market Attractiveness Analysis, By Application
  • Figure 122: Asia Pacific Stromal Vascular Fraction Market Attractiveness Analysis, By End User
  • Figure 123: Asia Pacific Stromal Vascular Fraction Market Attractiveness Analysis, By Isolation Products
  • Figure 124: South Korea Stromal Vascular Fraction Market Value Share, By Products (2017)
  • Figure 125: South Korea Stromal Vascular Fraction Market Value Share, By Application (2017)
  • Figure 126: South Korea Stromal Vascular Fraction Market Value Share, By End User (2017)
  • Figure 127: South Korea Stromal Vascular Fraction Market Value (US$ Mn) 2017E and 2025F
  • Figure 128: South Korea Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 129: South Korea Stromal Vascular Fraction Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 130: South Korea Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Isolation Products
  • Figure 131: South Korea Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Isolation Products
  • Figure 132: South Korea Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Aspiration Products
  • Figure 133: South Korea Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Aspiration Products
  • Figure 134: South Korea Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Transfer Products
  • Figure 135: South Korea Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Transfer Products
  • Figure 136: South Korea Stromal Vascular Fraction Market Attractiveness Analysis, By Products
  • Figure 137: South Korea Stromal Vascular Fraction Market Attractiveness Analysis, By Isolation Products
  • Figure 138: South Korea Stromal Vascular Fraction Market Attractiveness Analysis, By Application
  • Figure 139: South Korea Stromal Vascular Fraction Market Attractiveness Analysis, By End User
  • Figure 140: MEA Stromal Vascular Fraction Market Value Share, By Country (2017)
  • Figure 141: MEA Stromal Vascular Fraction Market Value Share, By Products (2017)
  • Figure 142: MEA Stromal Vascular Fraction Market Value Share, By Application (2017)
  • Figure 143: MEA Stromal Vascular Fraction Market Value Share, By End User (2017)
  • Figure 144: MEA Stromal Vascular Fraction Market Value (US$ Mn) 2017E and 2025F
  • Figure 145: MEA Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 146: MEA Stromal Vascular Fraction Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 147: GCC Countries Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 148: GCC Countries Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 149: South Africa Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 150: South Africa Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 151: Rest of MEA Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016
  • Figure 152: Rest of MEA Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 153: MEA Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Isolation Products
  • Figure 154: MEA Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Isolation Products
  • Figure 155: MEA Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Aspiration Products
  • Figure 156: MEA Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Aspiration Products
  • Figure 157: MEA Stromal Vascular Fraction Market Size (US$ Mn) Analysis, 2012-2016, By SVF Transfer Products
  • Figure 158: MEA Stromal Vascular Fraction Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2025, By SVF Transfer Products
  • Figure 159: MEA Stromal Vascular Fraction Market Attractiveness Analysis, By Country
  • Figure 160: MEA Stromal Vascular Fraction Market Attractiveness Analysis, By Products
  • Figure 161: MEA Stromal Vascular Fraction Market Attractiveness Analysis, By Application
  • Figure 162: MEA Stromal Vascular Fraction Market Attractiveness Analysis, By End User
  • Figure 163: MEA Stromal Vascular Fraction Market Attractiveness Analysis, By Isolation Products
  • Figure 164: Global Stromal Vascular Fraction Market Share Analysis (%) By Region, 2017 & 2025
  • Figure 165: Global Stromal Vascular Fraction Market Y-o-Y Growth (%) By Region, 2016-2025
  • Figure 166: Global Stromal Vascular Fraction Market Attractiveness Analysis By Region, 2017-2025
  • Figure 167: Global Stromal Vascular Fraction Market Share Analysis (%) By Products, 2017 & 2025
  • Figure 168: Global Stromal Vascular Fraction Market Y-o-Y Growth (%) By Products, 2016-2025
  • Figure 169: Global Stromal Vascular Fraction Market Attractiveness Analysis By Products, 2017-2025
  • Figure 170: Global Stromal Vascular Fraction Market Attractiveness Analysis, By SVF Isolation Products
  • Figure 171: Global Stromal Vascular Fraction Market Share Analysis (%) By Application, 2017 & 2025
  • Figure 172: Global Stromal Vascular Fraction Market Y-o-Y Growth (%) By Application, 2016-2025
  • Figure 173: Global Stromal Vascular Fraction Market Attractiveness Analysis By Application, 2017-2025
  • Figure 174: Global Stromal Vascular Fraction Market Share Analysis (%) By End User, 2017 & 2025
  • Figure 175: Global Stromal Vascular Fraction Market Y-o-Y Growth (%) By End User, 2016-2025
  • Figure 176: Global Stromal Vascular Fraction Market Attractiveness Analysis By End User, 2017-2025
  • Figure 177: Global Stromal Vascular Fraction Market Value Analysis and Forecast, 2016-2025 (US$ Mn)
  • Figure 178: Global Stromal Vascular Fraction Market Absolute $ Opportunity (US$ Mn), 2016-2025
Back to Top